US5252334A
(en)
*
|
1989-09-08 |
1993-10-12 |
Cygnus Therapeutic Systems |
Solid matrix system for transdermal drug delivery
|
US6492349B1
(en)
*
|
1993-03-31 |
2002-12-10 |
Nutramax Laboratories, Inc. |
Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
|
JPH08512054A
(ja)
*
|
1993-06-25 |
1996-12-17 |
アルザ・コーポレーション |
経皮系におけるポリ−n−ビニルアミドの含有
|
DE4442999A1
(de)
|
1994-12-02 |
1996-06-05 |
Hexal Pharma Gmbh |
Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten
|
DE4443888A1
(de)
*
|
1994-12-09 |
1996-06-13 |
Bayer Ag |
Dermal applizierbare Formulierungen von Parasitiziden
|
IL116539A
(en)
*
|
1995-01-06 |
2002-02-10 |
Noven Pharma |
Preparations given through the skin of unstable anti-acid drugs
|
US6024974A
(en)
*
|
1995-01-06 |
2000-02-15 |
Noven Pharmaceuticals, Inc. |
Composition and methods for transdermal delivery of acid labile drugs
|
DE19503338C2
(de)
*
|
1995-02-02 |
1998-07-30 |
Lohmann Therapie Syst Lts |
Arzneiform zur Abgabe von Kollagenase an Wunden und Verfahren zu ihrer Herstellung und ihre Verwendung
|
DE19512181C2
(de)
*
|
1995-03-31 |
2003-11-06 |
Hexal Pharma Gmbh |
Transdermales System mit Ramipril und/oder Trandolapril als ACE-Hemmer
|
AUPN262595A0
(en)
*
|
1995-04-24 |
1995-05-18 |
Novapharm Research (Australia) Pty Limited |
Biocidal surface films
|
US6730294B1
(en)
|
1995-04-24 |
2004-05-04 |
Novapharm Research (Australia) Pty Limited |
Method of forming a water soluble biocidal film on a solid surface
|
NZ309980A
(en)
*
|
1995-06-07 |
2001-06-29 |
Noven Pharma |
Transdermal composition containing a blend of one or more polymers, one or more drugs that has a low molecular weight and is liquid at room temperature
|
IL122432A
(en)
†
|
1995-06-07 |
2000-07-16 |
Cygnus Therapeutic Systems |
Transdermal patch for preventing ovulation
|
US6316022B1
(en)
*
|
1995-06-07 |
2001-11-13 |
Noven Pharmaceuticals, Inc. |
Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
|
US5780050A
(en)
*
|
1995-07-20 |
1998-07-14 |
Theratech, Inc. |
Drug delivery compositions for improved stability of steroids
|
FR2739031B1
(fr)
*
|
1995-09-27 |
1997-11-21 |
Lhd Lab Hygiene Dietetique |
Systeme matriciel transdermique d'administration d'un oestrogene et/ou d'un progestatif a base de copolymere styrene-isoprene-styrene, procede de preparation et utilisation en therapeutique
|
US5702720A
(en)
*
|
1995-12-22 |
1997-12-30 |
Minnesota Mining And Manufacturing Company |
Transdermal device for the delivery of flurbiprofen
|
ES2151464T3
(es)
*
|
1996-02-07 |
2002-12-16 |
Lead Chem Co Ltd |
Preparacion para aplicacion externa que comprende tranilast y procedimiento para producirla.
|
US5725876A
(en)
*
|
1996-05-17 |
1998-03-10 |
Noven Pharmaceuticals Inc., |
Compositions and methods for using low-swell clays in nicotine containing dermal compositions
|
US6623752B1
(en)
*
|
1996-07-02 |
2003-09-23 |
Hexal Ag |
Patch for transdermal application for pergolid
|
DE19635883A1
(de)
*
|
1996-09-04 |
1998-03-05 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit einer Östriol enthaltenden Wirkstoffkombination
|
US6290986B1
(en)
|
1996-10-24 |
2001-09-18 |
Pharmaceutical Applications Associates, Llc |
Method and composition for transdermal administration of pharmacologic agents
|
US6572880B2
(en)
|
1996-10-24 |
2003-06-03 |
Pharmaceutical Applications Associates Llc |
Methods and transdermal compositions for pain relief
|
US6479074B2
(en)
|
1996-10-24 |
2002-11-12 |
Pharmaceutical Applications Associates Llc |
Methods and transdermal compositions for pain relief
|
DE19646392A1
(de)
*
|
1996-11-11 |
1998-05-14 |
Lohmann Therapie Syst Lts |
Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
|
US20060002949A1
(en)
|
1996-11-14 |
2006-01-05 |
Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. |
Transcutaneous immunization without heterologous adjuvant
|
WO1998027982A1
(fr)
*
|
1996-12-24 |
1998-07-02 |
Sumitomo Pharmaceuticals Co., Ltd. |
Composition contenant de l'acide ascorbique
|
US5968547A
(en)
*
|
1997-02-24 |
1999-10-19 |
Euro-Celtique, S.A. |
Method of providing sustained analgesia with buprenorphine
|
DK48997A
(da)
|
1997-04-30 |
1999-01-05 |
Coloplast As |
Klæbemiddel samt anvendelse af dette middel
|
IT1292129B1
(it)
*
|
1997-06-11 |
1999-01-25 |
Sunnimex Ltd |
Medicamento utile per ridurre la massa grassa ed aumentare la massa magra nella donna in menopausa ed in entrambi i sessi nella
|
CA2294480C
(en)
*
|
1997-06-23 |
2008-05-20 |
Queen's University At Kingston |
Microdose therapy of female sexual dysfunction by no, co, and their donors
|
US7150881B2
(en)
*
|
1997-06-26 |
2006-12-19 |
Mylan Technologies, Inc. |
Adhesive mixture for transdermal delivery of highly plasticizing drugs
|
EA002526B1
(ru)
*
|
1997-08-21 |
2002-06-27 |
П.Н.Геролиматос С.А. |
Применение фанхинона для лечения болезни альцгеймера
|
US6488940B2
(en)
|
1997-08-21 |
2002-12-03 |
Johnson & Johnson Consumer Companies, Inc. |
Use of 17-α-estradiol for the treatment of aged or sundamaged skin and/or skin atrophy
|
AU754680B2
(en)
*
|
1997-08-21 |
2002-11-21 |
Johnson & Johnson Consumer Companies, Inc. |
Use of 17-alpha-estradiol for the treatment of aged or sundamaged skin and/or skin atrophy
|
AU5155198A
(en)
*
|
1997-08-28 |
1999-03-22 |
Robert Murdock |
Method and composition for transdermal administration of pharmacologic agent
|
DE19738643C2
(de)
*
|
1997-09-04 |
2001-10-04 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit dem Wirkstoff Scopolaminbase und Verfahren zu seiner Herstellung
|
US6767902B2
(en)
*
|
1997-09-17 |
2004-07-27 |
The Population Council, Inc. |
Androgen as a male contraceptive and non-contraceptive androgen replacement
|
GB9720470D0
(en)
*
|
1997-09-25 |
1997-11-26 |
Ethical Pharmaceuticals South |
Inhibition of crystallization in transdermal devices
|
US20040018241A1
(en)
*
|
1997-09-26 |
2004-01-29 |
Noven Pharmaceuticals, Inc. |
Bioadhesive compositions and methods for topical administration of active agents
|
EP1021204B1
(en)
*
|
1997-09-26 |
2005-12-28 |
Noven Pharmaceuticals, Inc. |
Bioadhesive compositions and methods for topical administration of active agents
|
JP3460538B2
(ja)
*
|
1997-10-08 |
2003-10-27 |
救急薬品工業株式会社 |
速溶性フィルム製剤
|
AU1800099A
(en)
*
|
1997-11-25 |
1999-06-15 |
Theratech, Inc. |
Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties
|
JP3930984B2
(ja)
*
|
1997-12-12 |
2007-06-13 |
日東電工株式会社 |
経皮吸収型製剤
|
US20020102291A1
(en)
*
|
1997-12-15 |
2002-08-01 |
Noven Pharmaceuticals, Inc. |
Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
|
US6210705B1
(en)
|
1997-12-15 |
2001-04-03 |
Noven Pharmaceuticals, Nc. |
Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
|
US6146656A
(en)
*
|
1998-01-22 |
2000-11-14 |
Nitto Denko Corporation |
Percutaneous absorption preparation
|
CA2323749A1
(en)
*
|
1998-03-06 |
1999-09-10 |
William E. Sponsel |
Composition and method for treating macular disorders
|
DE19814084B4
(de)
|
1998-03-30 |
2005-12-22 |
Lts Lohmann Therapie-Systeme Ag |
D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
|
DE19814257A1
(de)
|
1998-03-31 |
1999-10-07 |
Asta Medica Ag |
Brauseformulierungen
|
US6372254B1
(en)
*
|
1998-04-02 |
2002-04-16 |
Impax Pharmaceuticals Inc. |
Press coated, pulsatile drug delivery system suitable for oral administration
|
WO1999055396A1
(en)
*
|
1998-04-27 |
1999-11-04 |
Surmodics, Inc. |
Bioactive agent release coating
|
US20050196431A1
(en)
*
|
1998-04-30 |
2005-09-08 |
Upvan Narang |
Adhesive applicator tip with a polymerization initiator, polymerization rate modifier, and/or bioactive material
|
US6455064B1
(en)
|
1998-04-30 |
2002-09-24 |
Closure Medical Corporation |
Method of applying an adhesive composition over a bioactive polymerization initiator or accelerator
|
US6197347B1
(en)
|
1998-06-29 |
2001-03-06 |
Andrx Pharmaceuticals, Inc. |
Oral dosage for the controlled release of analgesic
|
IT1299566B1
(it)
*
|
1998-07-17 |
2000-03-16 |
Ifi Istituto Farmacoterapico I |
Cerotto transdermico e composizioni farmaceutiche comprendenti r (-)- norapropilapomorfina cloridrato e/o s (+) - norapropilapomorfina
|
US6699497B1
(en)
*
|
1998-07-24 |
2004-03-02 |
Alza Corporation |
Formulations for the transdermal administration of fenoldopam
|
EP1100476B1
(en)
*
|
1998-07-24 |
2004-06-16 |
ALZA Corporation |
Formulations for the transdermal administration of fenoldopam
|
JP3943724B2
(ja)
*
|
1998-07-31 |
2007-07-11 |
東光薬品工業株式会社 |
フェンタニル含有経皮投与マトリックス型貼付剤
|
US20040170675A1
(en)
*
|
1998-08-03 |
2004-09-02 |
Easterling W. Jerry |
Noninvasive method for treating cellulite through transdermal delivery of calcium channel blocker agents and medicament for use in such method
|
DK1105096T3
(da)
*
|
1998-08-19 |
2004-03-08 |
Skyepharma Canada Inc |
Injicerbare vandige propofoldispersioner
|
HUP0104168A3
(en)
*
|
1998-08-20 |
2003-04-28 |
3M Innovative Properties Co |
Spray on bandage and drug delivery system
|
IL142168A0
(en)
*
|
1998-10-02 |
2002-03-10 |
3M Innovative Properties Co |
Mucosal originated drug delivery systems and animal applications
|
US7001609B1
(en)
|
1998-10-02 |
2006-02-21 |
Regents Of The University Of Minnesota |
Mucosal originated drug delivery systems and animal applications
|
US6475514B1
(en)
|
1998-12-03 |
2002-11-05 |
Andrew Blitzer |
Athletic patch
|
AU778992B2
(en)
*
|
1998-12-07 |
2004-12-23 |
Agi Therapeutics Research Limited |
Transdermal patch for delivering volatile liquid drugs
|
US20030170195A1
(en)
*
|
2000-01-10 |
2003-09-11 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for drug delivery
|
ES2237415T5
(es)
*
|
1999-01-14 |
2008-12-16 |
Noven Pharmaceuticals, Inc. |
Composiciones dermicas.
|
US6337086B1
(en)
|
1999-02-06 |
2002-01-08 |
Dow Corning Corporation |
Pressure sensitive adhesive compositions for transdermal drug delivery devices
|
DE19906152B4
(de)
|
1999-02-10 |
2005-02-10 |
Jenapharm Gmbh & Co. Kg |
Wirkstoffhaltige Laminate für Transdermalsysteme
|
US6224888B1
(en)
|
1999-02-12 |
2001-05-01 |
The Procter & Gamble Company |
Cosmetic compositions
|
US6455055B1
(en)
|
1999-02-12 |
2002-09-24 |
The Procter & Gamble Company |
Cosmetic compositions
|
US6309657B2
(en)
|
1999-02-12 |
2001-10-30 |
The Procter & Gamble Company |
Cosmetic compositions
|
US6325993B1
(en)
*
|
1999-03-03 |
2001-12-04 |
Nitto Denko Corporation |
Oral adhesive sheet and oral adhesive preparation
|
US7063859B1
(en)
|
1999-04-28 |
2006-06-20 |
Noven Pharmaceuticals, Inc. |
Barrier film lined backing layer composition and method for topical administration of active agents
|
WO2000074661A2
(en)
|
1999-06-05 |
2000-12-14 |
Noven Pharmaceuticals, Inc. |
Solubility enhancement of drugs in transdermal drug delivery systems and methods of use
|
DE19929197A1
(de)
*
|
1999-06-25 |
2000-12-28 |
Novosis Pharma Ag |
Transdermalsysteme zur Abgabe von 5-HT3-Rezeptor-Antagonisten und ihre Verwendung zur antiemitischen Behandlung
|
CA2374930C
(en)
*
|
1999-07-02 |
2008-08-05 |
Lts Lohmann Therapie-Systeme Ag |
Microreservoir system based on polysiloxanes and ambiphilic solvents
|
US6316020B1
(en)
|
1999-08-26 |
2001-11-13 |
Robert R. Whittle |
Pharmaceutical formulations
|
US6268385B1
(en)
|
1999-08-26 |
2001-07-31 |
Robert R. Whittle |
Dry blend pharmaceutical formulations
|
US6369087B1
(en)
|
1999-08-26 |
2002-04-09 |
Robert R. Whittle |
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6262086B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
US6312712B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Method of improving bioavailability
|
US6326384B1
(en)
|
1999-08-26 |
2001-12-04 |
Robert R. Whittle |
Dry blend pharmaceutical unit dosage form
|
US6780880B1
(en)
|
1999-08-26 |
2004-08-24 |
Robert R. Whittle |
FT-Raman spectroscopic measurement
|
US6262085B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6312723B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
EP1221315A4
(en)
*
|
1999-10-13 |
2007-12-12 |
Senju Pharma Co |
ADHESIVE OPHTHALMIC PREPARATIONS FOR PERCUTANEOUS SPREADING
|
EP1231877A4
(en)
*
|
1999-11-04 |
2009-03-18 |
Xel Herbaceuticals |
TRANSDERMALE ADMINISTRATION OF HUPERZIN
|
US20050042271A1
(en)
*
|
1999-11-19 |
2005-02-24 |
Xel Herbaceuticals, Inc . |
Transdermal delivery system for alkaloids of aconitum species
|
CN100409847C
(zh)
*
|
1999-11-19 |
2008-08-13 |
美国爱科赛尔制药有限公司 |
乌头属生物碱经皮给药系统
|
US6896898B1
(en)
|
1999-11-19 |
2005-05-24 |
Xel Herbaceuticals, Inc. |
Transdermal delivery system for alkaloids of aconitum species
|
US6974588B1
(en)
*
|
1999-12-07 |
2005-12-13 |
Elan Pharma International Limited |
Transdermal patch for delivering volatile liquid drugs
|
US7732404B2
(en)
*
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
WO2001052823A2
(en)
|
2000-01-20 |
2001-07-26 |
Noven Pharmaceuticals, Inc. |
Compositions to effect the release profile in the transdermal administration of drugs
|
US6730691B1
(en)
|
2000-02-10 |
2004-05-04 |
Miles A. Galin |
Uses of alpha adrenergic blocking agents
|
US6905016B2
(en)
*
|
2000-03-14 |
2005-06-14 |
Noven Pharmaceuticals, Inc. |
Packaging system for transdermal drug delivery systems
|
US20070141107A1
(en)
*
|
2000-03-15 |
2007-06-21 |
Orbusneich Medical, Inc. |
Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device
|
US9522217B2
(en)
|
2000-03-15 |
2016-12-20 |
Orbusneich Medical, Inc. |
Medical device with coating for capturing genetically-altered cells and methods for using same
|
US8088060B2
(en)
|
2000-03-15 |
2012-01-03 |
Orbusneich Medical, Inc. |
Progenitor endothelial cell capturing with a drug eluting implantable medical device
|
DE10012908B4
(de)
*
|
2000-03-16 |
2005-03-17 |
Lts Lohmann Therapie-Systeme Ag |
Stabilisierte übersättigte transdermale therapeutische Matrixsysteme und Verfahren zu ihrer Herstellung
|
FR2806625B1
(fr)
*
|
2000-03-23 |
2002-08-30 |
Pf Medicament |
Dispositif matriciel pour l'administration transdermique de rilmenidine et son procede de preparation
|
WO2001074356A1
(en)
*
|
2000-04-03 |
2001-10-11 |
F. Hoffmann-La Roche Ag |
Concentrated solutions of carvedilol
|
US7179483B2
(en)
*
|
2000-04-26 |
2007-02-20 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
KR100452972B1
(ko)
*
|
2000-05-16 |
2004-10-14 |
주식회사 삼양사 |
경피투여용 하이드로젤 조성물
|
DE10025971B4
(de)
*
|
2000-05-25 |
2004-09-02 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System in Plasterform mit verminderter Tendenz zur Wirkstoffkristallisation und seine Verwendung
|
US6579544B1
(en)
|
2000-05-31 |
2003-06-17 |
Nutriex, L.L.C. |
Method for supplementing the diet
|
USRE44145E1
(en)
|
2000-07-07 |
2013-04-09 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
JP4837877B2
(ja)
*
|
2000-08-22 |
2011-12-14 |
日油株式会社 |
コンタクトレンズ用装着液
|
DE10043321B4
(de)
*
|
2000-08-24 |
2005-07-28 |
Neurobiotec Gmbh |
Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
|
US20070243240A9
(en)
*
|
2000-08-24 |
2007-10-18 |
Fred Windt-Hanke |
Transdermal therapeutic system
|
DE10053397A1
(de)
*
|
2000-10-20 |
2002-05-02 |
Schering Ag |
Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
|
DE10041478A1
(de)
*
|
2000-08-24 |
2002-03-14 |
Sanol Arznei Schwarz Gmbh |
Neue pharmazeutische Zusammensetzung
|
US6503894B1
(en)
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
AU2001292781A1
(en)
*
|
2000-09-19 |
2002-04-02 |
National Starch And Chemical Investment Holding Corporation |
Acryl adhesive useful in transdermal drug delivery systems
|
US20020119187A1
(en)
|
2000-09-29 |
2002-08-29 |
Cantor Adam S. |
Composition for the transdermal delivery of fentanyl
|
WO2002032431A1
(fr)
*
|
2000-10-16 |
2002-04-25 |
Hisamitsu Pharmaceutical Co., Inc. |
Compositions pour preparations externes
|
MXPA03003401A
(es)
*
|
2000-10-16 |
2004-06-30 |
Neopharm Inc |
Formulacion liposomica de mitoxantrona.
|
WO2002054996A2
(en)
*
|
2000-10-23 |
2002-07-18 |
Euro Celtique Sa |
Terazosin transdermal device and methods
|
GB0026137D0
(en)
*
|
2000-10-25 |
2000-12-13 |
Euro Celtique Sa |
Transdermal dosage form
|
EP1340496A4
(en)
*
|
2000-11-07 |
2004-04-14 |
Hisamitsu Pharmaceutical Co |
PHARMACEUTICAL PREPARATION OF THE PERCUTANEOUS ABSORPTION TYPE
|
KR20020037616A
(ko)
*
|
2000-11-15 |
2002-05-22 |
서경배 |
케토롤락의 경피흡수제제
|
WO2002045701A2
(en)
*
|
2000-12-05 |
2002-06-13 |
Noven Pharmaceuticals, Inc. |
Crystallization inhibition of drugs in transdermal drug delivery systems
|
DE10064453A1
(de)
*
|
2000-12-16 |
2002-07-04 |
Schering Ag |
Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
|
EP1216699A1
(de)
*
|
2000-12-21 |
2002-06-26 |
Schering Aktiengesellschaft |
Transdermalsystem enthaltend ein hochpotentes Gestagen
|
US6479076B2
(en)
*
|
2001-01-12 |
2002-11-12 |
Izhak Blank |
Nicotine delivery compositions
|
US20030032675A1
(en)
*
|
2001-02-15 |
2003-02-13 |
Franz G. Andrew |
Manufacture of thyroid hormone tablets having consistent active moiety amounts
|
BR0207297A
(pt)
*
|
2001-02-15 |
2005-04-19 |
King Pharmaceuticals Inc |
Composição farmacêutica em forma sólida e método de preparar uma forma de dosagem sólida de um ingrediente farmaceuticamente ativo
|
US6555581B1
(en)
|
2001-02-15 |
2003-04-29 |
Jones Pharma, Inc. |
Levothyroxine compositions and methods
|
US20030224047A1
(en)
*
|
2001-02-15 |
2003-12-04 |
Franz G. Andrew |
Levothyroxine compositions and methods
|
US7988991B2
(en)
*
|
2001-03-07 |
2011-08-02 |
Hisamitsu Pharmaceutical Co., Inc. |
Adhesive patch
|
DE20221247U1
(de)
|
2001-03-16 |
2005-09-15 |
Alza Corp |
Transdermal-Pflaster zum Verabreichen von Fentanyl
|
US20050208117A1
(en)
*
|
2001-03-16 |
2005-09-22 |
Venkatraman Subramanian S |
Transdermal administration of fentanyl and analogs thereof
|
ATE364380T1
(de)
*
|
2001-03-16 |
2007-07-15 |
Alza Corp |
Transdermales pflaster zur verabreichung von fentanyl
|
US6500406B1
(en)
*
|
2001-03-19 |
2002-12-31 |
The Procter & Gamble Company |
Denture care compositions and kits
|
US6509007B2
(en)
*
|
2001-03-19 |
2003-01-21 |
The Procter & Gamble Company |
Oral care kits and compositions
|
US6514484B2
(en)
*
|
2001-03-19 |
2003-02-04 |
The Procter & Gamble Company |
Systems for delivering a cosmetic and/or therapeutic active to oral surfaces using an integral carrier
|
US6491896B1
(en)
*
|
2001-03-19 |
2002-12-10 |
The Proctor & Gamble Company |
Polybutene containing denture cleanser compositions
|
DE10118282A1
(de)
*
|
2001-04-12 |
2002-12-05 |
Lohmann Therapie Syst Lts |
Haftkleber auf Basis von Ethylen-Vinylacetat-Copolymeren und Klebharzen, für medizinische Verwendungszwecke
|
DE60233217D1
(de)
|
2001-05-01 |
2009-09-17 |
Corium Internat Inc |
Hydrogel-zusammensetzungen
|
US20050113510A1
(en)
|
2001-05-01 |
2005-05-26 |
Feldstein Mikhail M. |
Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
|
US8206738B2
(en)
|
2001-05-01 |
2012-06-26 |
Corium International, Inc. |
Hydrogel compositions with an erodible backing member
|
US20050215727A1
(en)
*
|
2001-05-01 |
2005-09-29 |
Corium |
Water-absorbent adhesive compositions and associated methods of manufacture and use
|
EP1390084B1
(en)
|
2001-05-01 |
2011-03-23 |
A.V. Topchiev Institute of Petrochemical Synthesis |
Two-phase, water-absorbent bioadhesive composition
|
US8840918B2
(en)
|
2001-05-01 |
2014-09-23 |
A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences |
Hydrogel compositions for tooth whitening
|
US8541021B2
(en)
|
2001-05-01 |
2013-09-24 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Hydrogel compositions demonstrating phase separation on contact with aqueous media
|
US20030027833A1
(en)
*
|
2001-05-07 |
2003-02-06 |
Cleary Gary W. |
Compositions and delivery systems for administration of a local anesthetic agent
|
US20030026830A1
(en)
*
|
2001-05-08 |
2003-02-06 |
Thomas Lauterback |
Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
|
EP1256339B1
(en)
*
|
2001-05-08 |
2003-10-15 |
Schwarz Pharma Ag |
Transdermal therapeutic system for Parkinson's disease inducing high plasma levels of rotigotine
|
US20030027793A1
(en)
*
|
2001-05-08 |
2003-02-06 |
Thomas Lauterback |
Transdermal treatment of parkinson's disease
|
JP4865958B2
(ja)
*
|
2001-05-23 |
2012-02-01 |
株式会社トクホン |
鎮痛抗炎症局所作用型の貼付剤
|
CN100391462C
(zh)
*
|
2001-06-18 |
2008-06-04 |
诺芬药品公司 |
增强的透皮给药系统
|
US7244703B2
(en)
*
|
2001-06-22 |
2007-07-17 |
Bentley Pharmaceuticals, Inc. |
Pharmaceutical compositions and methods for peptide treatment
|
DE10141651B4
(de)
|
2001-08-24 |
2007-02-15 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
|
DE10137082A1
(de)
*
|
2001-07-28 |
2003-02-13 |
Hexal Ag |
Matrixkontrolliertes transdermales therapeutisches System zur Anwendung von Pramiprexol und Ropinirol
|
DE10137162A1
(de)
*
|
2001-07-30 |
2003-02-20 |
Hexal Ag |
Matrixkontrolliertes transdermales therapeutisches System zur Anwendung von Pramiprexol und Ropinirol
|
US20030198671A1
(en)
*
|
2001-08-10 |
2003-10-23 |
Franz G. Andrew |
Levothyroxine compositions having unique plasma AUC properties
|
US20030198667A1
(en)
*
|
2001-08-10 |
2003-10-23 |
Franz Andrew G. |
Methods of producing dispersible pharmaceutical compositions
|
US20030180353A1
(en)
*
|
2001-08-10 |
2003-09-25 |
Franz G. Andrew |
Stabilized pharmaceutical compositions
|
US20030190349A1
(en)
*
|
2001-08-10 |
2003-10-09 |
Franz G. Andrew |
Methods of stabilizing pharmaceutical compositions
|
US20030199587A1
(en)
*
|
2001-08-14 |
2003-10-23 |
Franz G. Andrew |
Levothyroxine compositions having unique Cmax properties
|
US20030195253A1
(en)
*
|
2001-08-14 |
2003-10-16 |
Franz G. Andrew |
Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration
|
US20030199586A1
(en)
*
|
2001-08-14 |
2003-10-23 |
Franz G. Andrew |
Unique levothyroxine aqueous materials
|
US7101569B2
(en)
|
2001-08-14 |
2006-09-05 |
Franz G Andrew |
Methods of administering levothyroxine pharmaceutical compositions
|
US20030198672A1
(en)
*
|
2001-08-14 |
2003-10-23 |
Franz G. Andrew |
Levothyroxine compositions having unique triidothyronine plasma AUC properties
|
US20030203967A1
(en)
*
|
2001-08-14 |
2003-10-30 |
Franz G. Andrew |
Levothyroxine compositions having unique Tmax properties
|
DE10141650C1
(de)
|
2001-08-24 |
2002-11-28 |
Lohmann Therapie Syst Lts |
Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
|
US6805878B2
(en)
*
|
2001-09-13 |
2004-10-19 |
Noven Pharmaceuticals, Inc. |
Transdermal administration of ACE inhibitors
|
WO2003022270A1
(en)
*
|
2001-09-13 |
2003-03-20 |
Noven Pharmaceuticals, Inc. |
Transdermal administration of an enalapril ester
|
US20030082225A1
(en)
*
|
2001-10-19 |
2003-05-01 |
Mason Paul Arthur |
Sterile, breathable patch for treating wound pain
|
US20030171436A1
(en)
*
|
2001-10-29 |
2003-09-11 |
Franz G. Andrew |
Levothyroxine compositions having unique triiodothyronine Tmax properties
|
DE10157745A1
(de)
*
|
2001-11-24 |
2003-06-26 |
Hf Arzneimittelforsch Gmbh |
Transdermales therapeutisches System zur Verabreichung von 17alpha-Estradiol
|
US7165933B2
(en)
*
|
2001-12-04 |
2007-01-23 |
Kag Holding A/S |
Screw pump for transporting emulsions susceptible to mechanical handling
|
CN100594027C
(zh)
*
|
2001-12-05 |
2010-03-17 |
张喜田 |
番木鳖碱、马钱子碱和一叶秋碱及其盐的透皮剂
|
US20030147972A1
(en)
*
|
2002-02-05 |
2003-08-07 |
Christopher W. Denver |
Method and composition for diminishing loss of color in flavors and fragrances
|
JP2005519961A
(ja)
*
|
2002-03-11 |
2005-07-07 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
継続的スルファターゼ阻害プロゲストゲンホルモン補充療法
|
JP2005519964A
(ja)
*
|
2002-03-11 |
2005-07-07 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
スルファターゼ阻害プロゲストゲンのみの避妊レジメン
|
US20030219471A1
(en)
*
|
2002-03-11 |
2003-11-27 |
Caubel Patrick Michel |
Extended cycle estrogen and sulfatase inhibiting progestogen contraceptive regimens
|
DE10212864B4
(de)
*
|
2002-03-22 |
2005-12-22 |
Beiersdorf Ag |
Polymermatrizes umfassend ein Mischsystem zur Löslichkeitsvermittlung von pharmazeutischen Wirkstoffen, Verfahren zu deren Herstellung und deren Verwendung
|
JP4478757B2
(ja)
*
|
2002-04-19 |
2010-06-09 |
日東電工株式会社 |
ビソプロロール含有貼付剤
|
US8440220B2
(en)
*
|
2002-04-23 |
2013-05-14 |
Durect Corporation |
Transdermal analgesic systems with reduced abuse potential
|
DE10220230A1
(de)
*
|
2002-05-06 |
2003-11-27 |
Sanol Arznei Schwarz Gmbh |
Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms
|
AR033748A1
(es)
*
|
2002-05-15 |
2004-01-07 |
Thalas Group Inc |
Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
|
US7217853B2
(en)
*
|
2002-05-24 |
2007-05-15 |
Corium International, Inc. |
Composition for cushions, wound dressings and other skin-contacting products
|
US20040018237A1
(en)
*
|
2002-05-31 |
2004-01-29 |
Perricone Nicholas V. |
Topical drug delivery using phosphatidylcholine
|
US7097850B2
(en)
|
2002-06-18 |
2006-08-29 |
Surmodics, Inc. |
Bioactive agent release coating and controlled humidity method
|
KR20050045946A
(ko)
|
2002-06-25 |
2005-05-17 |
애크럭스 디디에스 피티와이 리미티드 |
비정질 약학적 조성물을 이용한 경피전달속도의 제어
|
US20040010035A1
(en)
*
|
2002-07-15 |
2004-01-15 |
Ciociola Arthur A. |
Gastrointestinal compositions
|
US6986901B2
(en)
*
|
2002-07-15 |
2006-01-17 |
Warner-Lambert Company Llc |
Gastrointestinal compositions
|
JP2005533101A
(ja)
*
|
2002-07-10 |
2005-11-04 |
ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー |
アロステリック阻害剤又はマトリックス金属タンパク質分解酵素−13の、セレコキシブでもバルデコキシブでもないシクロオキシゲナーゼ−2の選択的阻害剤との組合せ物
|
DE10234673B4
(de)
*
|
2002-07-30 |
2007-08-16 |
Schwarz Pharma Ag |
Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
|
US8246979B2
(en)
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system for the administration of rotigotine
|
US8246980B2
(en)
*
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system
|
US8211462B2
(en)
*
|
2002-07-30 |
2012-07-03 |
Ucb Pharma Gmbh |
Hot-melt TTS for administering rotigotine
|
US6958142B2
(en)
*
|
2002-08-02 |
2005-10-25 |
Balance Pharmaceuticals, Inc. |
Nasal spray formulation and method
|
JP4792193B2
(ja)
*
|
2002-08-28 |
2011-10-12 |
久光製薬株式会社 |
貼付剤
|
WO2004098472A1
(en)
*
|
2002-08-30 |
2004-11-18 |
Watson Pharmaceuticals, Inc. |
Transdermal delivery systems and methods
|
US20040086551A1
(en)
*
|
2002-10-30 |
2004-05-06 |
Miller Kenneth J. |
Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
|
EP1426049B1
(en)
*
|
2002-12-02 |
2005-05-18 |
Schwarz Pharma Ag |
Iontophoretic delivery of rotigotine for the treatment of Parkinson's disease
|
DE10261696A1
(de)
*
|
2002-12-30 |
2004-07-15 |
Schwarz Pharma Ag |
Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
|
PT1589973E
(pt)
*
|
2003-01-23 |
2010-07-09 |
Shire Holdings Ag |
FORMULAÃO E MéTODOS PARA O TRATAMENTO DE TROMBOCITEMIA
|
US20040147534A1
(en)
*
|
2003-01-23 |
2004-07-29 |
Foote Mary Ann |
Topical composition and method for treating occlusive wounds
|
GB0302662D0
(en)
*
|
2003-02-05 |
2003-03-12 |
Strakan Ltd |
Transdermal granisetron
|
DE10305137A1
(de)
*
|
2003-02-07 |
2004-08-26 |
Novosis Ag |
Transdermale therapeutische Abgabesysteme mit einem Butenolid
|
US9498454B2
(en)
*
|
2003-02-24 |
2016-11-22 |
Pharmaceutical Productions Inc. |
Transmucosal drug delivery system
|
JO2505B1
(en)
|
2003-03-14 |
2009-10-05 |
باير شيرنغ فارما اكتنجيسيلشافت |
Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
|
US20040208917A1
(en)
*
|
2003-04-16 |
2004-10-21 |
Wilfried Fischer |
Transdermal systems for the release of clonidine
|
EP1633408B1
(en)
*
|
2003-06-19 |
2016-08-17 |
Coloplast A/S |
A wound care device
|
US7816546B2
(en)
*
|
2003-06-30 |
2010-10-19 |
Richter Gedeon Vegyeszeti Gyar Rt. |
Process for the synthesis of high purity d-(17α)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yn-3-one-oxime
|
US20120058993A1
(en)
*
|
2003-07-23 |
2012-03-08 |
Douglas Pharmaceuticals Ltd. |
Stable Suspension Formulation
|
DE10334188B4
(de)
*
|
2003-07-26 |
2007-07-05 |
Schwarz Pharma Ag |
Verwendung von Rotigotin zur Behandlung von Depressionen
|
DE10334187A1
(de)
*
|
2003-07-26 |
2005-03-03 |
Schwarz Pharma Ag |
Substituierte 2-Aminotetraline zur Behandlung von Depressionen
|
US20050036957A1
(en)
*
|
2003-08-15 |
2005-02-17 |
Michael Prencipe |
Tooth whitening dental tray and method of use
|
US8815215B2
(en)
|
2003-08-15 |
2014-08-26 |
Colgate-Palmolive Company |
Hydrophobic tooth whitening system and methods of use
|
US20050187278A1
(en)
*
|
2003-08-28 |
2005-08-25 |
Pharmacia Corporation |
Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors
|
US8784874B2
(en)
|
2003-09-10 |
2014-07-22 |
Noven Pharmaceuticals, Inc. |
Multi-layer transdermal drug delivery device
|
DK1675908T3
(da)
*
|
2003-10-07 |
2009-04-20 |
Coloplast As |
Sammensætning der er nyttig som et adhæsiv samt anvendelse af en sådan sammensætning
|
US20070009582A1
(en)
*
|
2003-10-07 |
2007-01-11 |
Madsen Niels J |
Composition useful as an adhesive and use of such a composition
|
BRPI0414551B8
(pt)
|
2003-10-10 |
2021-05-25 |
Antares Pharma Ipl Ag |
formulação farmacêutica transdérmica ou transmucosa e método de protelação ou inibição da cristalização de um agente ativo
|
US7387788B1
(en)
|
2003-10-10 |
2008-06-17 |
Antares Pharma Ipl Ag |
Pharmaceutical compositions of nicotine and methods of use thereof
|
ME00114B
(me)
*
|
2003-10-28 |
2011-02-10 |
Noven Pharma |
Kompozicije i postupci za kontrolisanje gubitka i oslobađanja lijeka u transdermalnim sistemima oslobađanja lijeka
|
WO2005044243A2
(en)
|
2003-10-30 |
2005-05-19 |
Alza Corporation |
Transdermal analgesic systems having reduced abuse potential
|
WO2005046684A1
(en)
|
2003-11-04 |
2005-05-26 |
Shire Laboratories, Inc. |
Once daily dosage forms of trospium
|
MXPA06003769A
(es)
*
|
2003-11-04 |
2006-07-03 |
Shire Lab Inc |
Liberacion sostenida de moleculas farmacologicamente activas cargadas positivamente a partir de una matriz que contiene polimeros con atomos de oxigeno polarizados.
|
CA2536401C
(en)
|
2003-11-04 |
2011-08-30 |
Shire Laboratories Inc. |
Compositions of quaternary ammonium compounds containing bioavailability enhancers
|
DE602004028284D1
(de)
|
2003-12-08 |
2010-09-02 |
Cpex Pharmaceuticals Inc |
Pharmazeutische zusammensetzungen und verfahren für die insulinbehandlung
|
US20070128262A1
(en)
*
|
2004-01-30 |
2007-06-07 |
Satoshi Amano |
Package containing adhesive patch and method of inhibiting drug migration
|
CA2554649C
(en)
|
2004-01-30 |
2015-10-27 |
Corium International, Inc. |
Rapidly dissolving film for delivery of an active agent
|
US20080125485A1
(en)
|
2004-02-17 |
2008-05-29 |
Action Medicines |
Use of 2,5-Dihydroxybenzene Derivatives for Treating Actinic Keratosis
|
ES2238924B1
(es)
|
2004-02-17 |
2006-12-01 |
Investread Europa, S.L. |
Uso del acido 2,5-dihidroxibencenosulfonico, en la fabricacion de medicamentos de aplicacion en el tratamiento de enfermedades angiodependientes.
|
US20070149618A1
(en)
|
2004-02-17 |
2007-06-28 |
Action Medicines, S.L. |
Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis
|
US20050202073A1
(en)
*
|
2004-03-09 |
2005-09-15 |
Mylan Technologies, Inc. |
Transdermal systems containing multilayer adhesive matrices to modify drug delivery
|
US9205062B2
(en)
*
|
2004-03-09 |
2015-12-08 |
Mylan Pharmaceuticals, Inc. |
Transdermal systems containing multilayer adhesive matrices to modify drug delivery
|
JP2007532187A
(ja)
|
2004-04-06 |
2007-11-15 |
サーモディクス,インコーポレイティド |
生物活性物質のためのコーティング組成物
|
US20080138390A1
(en)
*
|
2004-04-07 |
2008-06-12 |
Tsung-Min Hsu |
Transdermal Delivery System For Use With Basic Permeation Enhancers
|
US20080226697A1
(en)
*
|
2004-04-21 |
2008-09-18 |
Hisamitsu Pharmaceutical Co., Inc. |
Patch for External Use with Elevated Content of Absorption Promoter in Pressure-Sensitive Adhesive Base
|
UA88464C2
(ru)
*
|
2004-04-29 |
2009-10-26 |
Колдуэлл Гейлер, Инк. |
Способ дермального введения метадоновой композиции с обеспечением системного действия
|
EP1611882B1
(en)
*
|
2004-06-01 |
2010-04-07 |
Hisamitsu Pharmaceutical Co., Inc. |
Adhesive patch
|
JPWO2005117886A1
(ja)
*
|
2004-06-01 |
2008-04-03 |
久光製薬株式会社 |
貼付剤
|
US20060024246A1
(en)
*
|
2004-07-29 |
2006-02-02 |
Prithwiraj Maitra |
Oral care compositions with film forming polymers
|
US7700608B2
(en)
*
|
2004-08-04 |
2010-04-20 |
Shire Holdings Ag |
Quinazoline derivatives and their use in the treatment of thrombocythemia
|
US20060030574A1
(en)
*
|
2004-08-04 |
2006-02-09 |
Shire Holdings Ag |
Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors
|
CN101039706A
(zh)
|
2004-08-05 |
2007-09-19 |
考里安国际公司 |
粘合剂组合物
|
US20060121102A1
(en)
*
|
2004-09-27 |
2006-06-08 |
Chia-Ming Chiang |
Transdermal systems for the delivery of estrogens and progestins
|
TW200616589A
(en)
*
|
2004-10-08 |
2006-06-01 |
Noven Pharma |
Transdermal delivery of drugs based on crystal size
|
WO2006041911A2
(en)
|
2004-10-08 |
2006-04-20 |
Noven Pharmaceuticals, Inc. |
Device transdermal administration of drugs including acrylic polymers
|
WO2006041907A2
(en)
*
|
2004-10-08 |
2006-04-20 |
Noven Pharmaceuticals, Inc. |
Transdermal delivery of estradiol
|
EP1807033B1
(en)
|
2004-10-08 |
2016-07-20 |
Noven Pharmaceuticals, Inc. |
Transdermal drug delivery device including an occlusive backing
|
DE602005015877D1
(de)
*
|
2004-10-19 |
2009-09-17 |
3M Innovative Properties Co |
Verfahren zur herstellung druckempfindlicher klebstoffe
|
US8246977B2
(en)
|
2004-10-21 |
2012-08-21 |
Durect Corporation |
Transdermal delivery systems
|
US8252319B2
(en)
|
2004-10-21 |
2012-08-28 |
Durect Corporation |
Transdermal delivery system for sufentanil
|
KR100810947B1
(ko)
*
|
2005-01-28 |
2008-03-10 |
롬 앤드 하아스 컴패니 |
에멀젼 폴리머로부터 제조된 의료용 필름 및 제품
|
WO2006080199A1
(ja)
|
2005-01-31 |
2006-08-03 |
Hisamitsu Pharmaceutical Co., Inc. |
貼付剤
|
JP4704764B2
(ja)
*
|
2005-02-03 |
2011-06-22 |
日東電工株式会社 |
爪貼付用粘着組成物および爪用貼付剤
|
US20080138388A1
(en)
*
|
2005-02-04 |
2008-06-12 |
Hisamitsu Pharmaceutical Co., Inc. |
Transdermal Absorption Patch
|
FR2881653A1
(fr)
*
|
2005-02-04 |
2006-08-11 |
Frederic Khodja |
Dispositif permettant l'administration en continu d'une dose physiologique controlee d'au moins un mineral ou une vitamine
|
EP1704859B1
(en)
*
|
2005-02-18 |
2010-08-11 |
Universitätsklinikum Freiburg |
Androgen receptor-dependent gene expression control by inhibiting the amine oxidase activity of lysine-specific demethylase (LSD1)
|
TW200640526A
(en)
*
|
2005-02-24 |
2006-12-01 |
Alza Corp |
Transdermal electrotransport drug delivery systems with reduced abuse potential
|
JP4873871B2
(ja)
*
|
2005-02-28 |
2012-02-08 |
久光製薬株式会社 |
粘着剤及び貼付剤
|
US7914810B2
(en)
*
|
2005-05-06 |
2011-03-29 |
Synthes Usa, Llc |
Methods for the in situ treatment of bone cancer
|
KR101413138B1
(ko)
*
|
2005-05-16 |
2014-07-01 |
노바팜 리서치(오스트레일리아)피티와이리미티드 |
환자의 수술 준비에 사용하기 위한 방법 및 조성물
|
US20060263421A1
(en)
*
|
2005-05-18 |
2006-11-23 |
Abeille Pharmaceuticals Inc |
Transdermal Method and Patch for Nausea
|
WO2006125642A1
(en)
|
2005-05-27 |
2006-11-30 |
Antares Pharma Ipl Ag |
Methods and apparatus for transdermal or transmucosal application of testosterone
|
WO2006130510A2
(en)
*
|
2005-05-27 |
2006-12-07 |
Taro Pharmaceuticals U.S.A., Inc. |
Stable liquid desoximethasone compositions with reduced oxidized impurity
|
EP1888048B1
(en)
*
|
2005-06-10 |
2012-01-04 |
3M Innovative Properties Company |
Method for handling adhesive laminate sections
|
US20060281775A1
(en)
*
|
2005-06-14 |
2006-12-14 |
Applied Pharmacy Services, Inc. |
Two-component pharmaceutical composition for the treatment of pain
|
CA2613114C
(en)
*
|
2005-06-27 |
2015-02-24 |
3M Innovative Properties Company |
Microneedle cartridge assembly and method of applying
|
JP5058531B2
(ja)
|
2005-09-09 |
2012-10-24 |
日東電工株式会社 |
ビソプロロール含有貼付製剤
|
US20070098772A1
(en)
*
|
2005-09-23 |
2007-05-03 |
Westcott Tyler D |
Transdermal norelgestromin delivery system
|
EP2308480B1
(en)
|
2005-09-23 |
2014-08-13 |
ALZA Corporation |
High Enhancer-Loading Polyacrylate Formulation for Transdermal Applications
|
WO2007035941A2
(en)
*
|
2005-09-23 |
2007-03-29 |
Alza Corporation |
Transdermal galantamine delivery system
|
US20090130188A9
(en)
*
|
2005-09-29 |
2009-05-21 |
National Starch And Chemical Investment Holding Company |
Acrylic pressure sensitive adhesives
|
GEP20125432B
(en)
|
2005-10-12 |
2012-03-26 |
Unimed Pharmaceuticals Llc |
Improved testosterone gel and use thereof
|
US20070087055A1
(en)
*
|
2005-10-14 |
2007-04-19 |
David Jan |
Directly compressible extended release alprazolam formulation
|
US8071125B2
(en)
|
2005-12-09 |
2011-12-06 |
Beijing Kangbeide Pharmaceutical Technology Development Co., Ltd. |
Transdermal patch containing isosorbide dinitrate and bisoprolol
|
JP4945228B2
(ja)
|
2005-12-13 |
2012-06-06 |
日東電工株式会社 |
ビソプロロール含有貼付製剤
|
US8124169B2
(en)
*
|
2005-12-14 |
2012-02-28 |
3M Innovative Properties Company |
Antimicrobial coating system
|
US9247736B2
(en)
*
|
2005-12-14 |
2016-02-02 |
3M Innovative Properties Company |
Antimicrobial adhesive films
|
US20070138439A1
(en)
*
|
2005-12-21 |
2007-06-21 |
3M Innovative Properties Company |
Denaturant for ethanol
|
SE530184C2
(sv)
*
|
2005-12-23 |
2008-03-18 |
Kjell Stenberg |
Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
|
FR2895679B1
(fr)
*
|
2005-12-29 |
2012-06-08 |
Pf Medicament |
Stabilisation de testosterone au sein de dispositifs transdermiques
|
JP2009528990A
(ja)
*
|
2006-02-13 |
2009-08-13 |
アヴィバ ドラッグ デリバリー システムズ |
スフェンタニルを含む接着性調製物およびそれを用いる方法
|
JP5037831B2
(ja)
*
|
2006-02-15 |
2012-10-03 |
久光製薬株式会社 |
凝集力向上及び徐放化の外用貼付剤
|
CA2643037C
(en)
*
|
2006-02-27 |
2014-08-05 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for delivery of amino-functional drugs
|
US8524273B2
(en)
*
|
2006-02-28 |
2013-09-03 |
Hisamitsu Pharmaceutical Co., Inc. |
Transdermal absorption preparation
|
DE102006019293A1
(de)
*
|
2006-04-21 |
2007-10-25 |
LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH |
Pflaster, enthaltend ein Fentanyl Analogum
|
CN101426475A
(zh)
|
2006-04-21 |
2009-05-06 |
安塔雷斯制药Ipl股份公司 |
使用用于经皮或经粘膜应用的制剂治疗热潮红的方法
|
US8673284B2
(en)
*
|
2006-05-03 |
2014-03-18 |
L'oreal |
Cosmetic compositions containing block copolymers, tackifiers and a selective solvent for hard blocks
|
US8557230B2
(en)
*
|
2006-05-03 |
2013-10-15 |
L'oreal |
Cosmetic compositions containing block copolymers, tackifiers and shine enhancing agents
|
US8758739B2
(en)
*
|
2006-05-03 |
2014-06-24 |
L'oreal |
Cosmetic compositions containing block copolymers, tackifiers and gelling agents
|
US8673283B2
(en)
*
|
2006-05-03 |
2014-03-18 |
L'oreal |
Cosmetic compositions containing block copolymers, tackifiers and a solvent mixture
|
US8673282B2
(en)
*
|
2006-05-03 |
2014-03-18 |
L'oreal |
Cosmetic compositions containing block copolymers, tackifiers and a selective solvent for soft blocks
|
US8778323B2
(en)
*
|
2006-05-03 |
2014-07-15 |
L'oréal |
Cosmetic compositions containing block copolymers, tackifiers and modified silicones
|
EP2024406B1
(en)
*
|
2006-06-06 |
2012-08-01 |
Dow Corning Corporation |
A silicone acrylate hybrid composition
|
US8569416B2
(en)
|
2006-06-06 |
2013-10-29 |
Dow Corning Corporation |
Single phase silicone acrylate formulation
|
US8614278B2
(en)
|
2006-06-06 |
2013-12-24 |
Dow Corning Corporation |
Silicone acrylate hybrid composition and method of making same
|
US20070287727A1
(en)
*
|
2006-06-08 |
2007-12-13 |
Jacob Hiller |
Anti-Nicotine Treatment
|
US9386770B2
(en)
*
|
2006-06-13 |
2016-07-12 |
Phibro Animal Health Corp. |
Use of predissolved pristinamycin-type and polyether ionophore type antimicrobial agents in the production of ethanol
|
WO2008001204A2
(en)
*
|
2006-06-29 |
2008-01-03 |
Antares Pharma Ipl Ag |
Transdermal compositions of pramipexole having enhanced permeation properties
|
TW200815045A
(en)
*
|
2006-06-29 |
2008-04-01 |
Jazz Pharmaceuticals Inc |
Pharmaceutical compositions of ropinirole and methods of use thereof
|
WO2008008281A2
(en)
|
2006-07-07 |
2008-01-17 |
Proteus Biomedical, Inc. |
Smart parenteral administration system
|
CN101528830A
(zh)
|
2006-07-10 |
2009-09-09 |
麦德医像公司 |
超弹性环氧水凝胶
|
ES2657887T3
(es)
*
|
2006-07-14 |
2018-03-07 |
Hisamitsu Pharmaceutical Co., Inc. |
Preparación adhesiva
|
US7731604B2
(en)
*
|
2006-10-31 |
2010-06-08 |
Taylor Made Golf Company, Inc. |
Golf club iron head
|
DE102006054731B4
(de)
|
2006-11-21 |
2013-02-28 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
|
US7910597B2
(en)
*
|
2006-11-28 |
2011-03-22 |
Shire Llc |
Substituted quinazolines
|
US8304420B2
(en)
|
2006-11-28 |
2012-11-06 |
Shire Llc |
Substituted quinazolines for reducing platelet count
|
US8603444B2
(en)
*
|
2007-01-12 |
2013-12-10 |
L'oréal |
Cosmetic compositions containing a block copolymer, a tackifier and a high viscosity ester
|
US8658141B2
(en)
*
|
2007-01-12 |
2014-02-25 |
L'oreal |
Cosmetic composition containing a block copolymer, a tackifier, a silsesquioxane wax and/or resin
|
US8703178B2
(en)
|
2007-03-08 |
2014-04-22 |
Nitto Denko Corporation |
Percutaneous administration device of bisoprolol
|
AU2008228903B2
(en)
|
2007-03-19 |
2013-03-07 |
Vita Sciences, Llc |
Transdermal patch and method for delivery of vitamin B12
|
DE102007020799A1
(de)
|
2007-05-03 |
2008-11-06 |
Novosis Ag |
Transdermales therapeutisches System mit Remifentanil
|
WO2008157323A1
(en)
*
|
2007-06-13 |
2008-12-24 |
3M Innovative Properties Company |
Antimicrobial film-forming composition, antimicrobial film, and method of verifying the presence of an antimicrobial film
|
CN101147739B
(zh)
|
2007-07-06 |
2010-12-08 |
北京康倍得医药技术开发有限公司 |
含罗替戈汀的组合物及其制药用途以及含该组合物的透皮贴剂
|
CA2696632C
(en)
*
|
2007-08-17 |
2014-05-27 |
Arcion Therapeutics, Inc. |
High concentration local anesthetic formulations
|
CN104398496B
(zh)
|
2007-10-15 |
2018-03-20 |
阿尔扎公司 |
芬太尼的一天更换一次透皮施用
|
US9125979B2
(en)
|
2007-10-25 |
2015-09-08 |
Proteus Digital Health, Inc. |
Fluid transfer port information system
|
US8419638B2
(en)
|
2007-11-19 |
2013-04-16 |
Proteus Digital Health, Inc. |
Body-associated fluid transport structure evaluation devices
|
CL2008003507A1
(es)
*
|
2007-11-26 |
2009-11-27 |
Neuroderm Ltd |
Composicion farmaceutica que comprende nicotina y un inhibidor de la desensibilizacion del receptor de acetilcolina nicotinico (nachr) opipramol; kit farmaceutico; dispositivo medico; y uso para tratar una enfermedad o trastorno del sistema nervioso central o periferico.
|
EP2227635A2
(en)
|
2007-12-03 |
2010-09-15 |
Medipacs, Inc. |
Fluid metering device
|
DE102008013701A1
(de)
*
|
2008-03-11 |
2009-09-17 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales Therapeutisches System mit stabilisierter Membran
|
US20090264806A1
(en)
|
2008-04-16 |
2009-10-22 |
Kei Tamura |
Transdermal drug administration device
|
EP2111857A1
(de)
*
|
2008-04-25 |
2009-10-28 |
Acino AG |
Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff hiervon
|
WO2009158120A2
(en)
*
|
2008-05-30 |
2009-12-30 |
Mylan Laboratories Inc. |
Stabilized transdermal drug delivery system
|
JP5368168B2
(ja)
*
|
2008-06-16 |
2013-12-18 |
日東電工株式会社 |
貼付剤及び貼付製剤
|
US20090318520A1
(en)
*
|
2008-06-20 |
2009-12-24 |
Afecta Pharmaceuticals Drive |
Use of isoindoles for the treatment of neurobehavioral disorders
|
US8231906B2
(en)
*
|
2008-07-10 |
2012-07-31 |
Noven Pharmaceuticals, Inc. |
Transdermal estrogen device and delivery
|
EP2307027A4
(en)
|
2008-07-11 |
2012-08-15 |
Neumedics |
TETRACYCLINE DERIVATIVES WITH REDUCED ANTIBIOTIC ACTIVITY AND NEUROPROTECTIVE PROPERTIES
|
WO2010014545A1
(en)
*
|
2008-07-28 |
2010-02-04 |
Dow Corning Corporation |
Composite article
|
WO2010019953A1
(en)
|
2008-08-15 |
2010-02-18 |
Arcion Therapeutics, Inc. |
High concentration local anesthetic formulations for treating non-neuropathic pain
|
DK2328561T3
(en)
*
|
2008-08-19 |
2016-02-08 |
Adcock Ingram Intellectual Property Pty Ltd |
Rate modulated administration of drugs from a three-layered tablet containing tramadol, diclofenac, paracetamol
|
JP5704801B2
(ja)
*
|
2008-08-21 |
2015-04-22 |
ニプロパッチ株式会社 |
粘着性組成物及び経皮吸収型製剤
|
CA2735418A1
(en)
*
|
2008-08-26 |
2010-03-11 |
Ray L. Hauser |
Substance delivery to skin and other tissues
|
BRPI0913809B1
(pt)
|
2008-10-02 |
2019-02-05 |
Mylan Inc |
método para produzir continuamente um laminado adesivo sensível á pressão multicamada
|
EP2387394B1
(en)
|
2009-01-14 |
2018-05-02 |
Corium International, Inc. |
Transdermal administration of tamsulosin
|
JP5664991B2
(ja)
*
|
2009-03-27 |
2015-02-04 |
トーアエイヨー株式会社 |
経皮吸収製剤
|
RU2544702C2
(ru)
|
2009-04-24 |
2015-03-20 |
Хенкель Корпорейшн |
Клеи на основе силикон-акрилового гибридного полимера
|
US8299079B2
(en)
|
2009-05-22 |
2012-10-30 |
Kaufman Herbert E |
Preparations and methods for ameliorating or reducing presbyopia
|
US20100298335A1
(en)
*
|
2009-05-22 |
2010-11-25 |
Kaufman Herbert E |
Preparations and Methods for Ameliorating or Reducing Presbyopia
|
JP5281973B2
(ja)
*
|
2009-07-06 |
2013-09-04 |
日東電工株式会社 |
ビソプロロール含有貼付剤
|
CN101618030B
(zh)
*
|
2009-08-10 |
2010-12-29 |
辽宁亿灵科创生物医药科技有限公司 |
一种雷公藤内酯醇透皮贴剂及其制备方法
|
US20110037455A1
(en)
*
|
2009-08-17 |
2011-02-17 |
Oren Navot |
System for measuring electrical power
|
US20090318568A1
(en)
*
|
2009-08-26 |
2009-12-24 |
Hauser Ray L |
Adherent coating for tissue surface and/or trans-tissue surface substance delivery
|
US9238102B2
(en)
|
2009-09-10 |
2016-01-19 |
Medipacs, Inc. |
Low profile actuator and improved method of caregiver controlled administration of therapeutics
|
US8221994B2
(en)
*
|
2009-09-30 |
2012-07-17 |
Cilag Gmbh International |
Adhesive composition for use in an immunosensor
|
KR20120089343A
(ko)
|
2009-11-19 |
2012-08-09 |
쓰리엠 이노베이티브 프로퍼티즈 컴파니 |
아크릴 중합체에 결합된 작용화 합성 고무와 합성 고무의 블렌드를 포함하는 감압 접착제
|
US8551781B2
(en)
|
2009-11-19 |
2013-10-08 |
The Regents Of The University Of California |
Vault complexes for facilitating biomolecule delivery
|
EP2501769B1
(en)
*
|
2009-11-19 |
2015-01-21 |
3M Innovative Properties Company |
Pressure sensitive adhesive comprising functionalized polyisobutylene hydrogen bonded to acylic polymer
|
WO2011068722A1
(en)
*
|
2009-12-01 |
2011-06-09 |
Noven Pharmaceuticals, Inc. |
Transdermal testosterone device and delivery
|
ES2679800T3
(es)
|
2009-12-22 |
2018-08-31 |
Lts Lohmann Therapie-Systeme Ag |
Polivinilpirrolidona para la estabilización de una dispersión sólida de la forma no cristalina de rotigotina
|
US20110172639A1
(en)
*
|
2010-01-08 |
2011-07-14 |
Ratio, Inc. |
Device and method for delivery of microneedle to desired depth within the skin
|
US20110172609A1
(en)
*
|
2010-01-08 |
2011-07-14 |
Ratio, Inc. |
Microneedle component assembly for drug delivery device
|
US20110172645A1
(en)
*
|
2010-01-08 |
2011-07-14 |
Ratio, Inc. |
Wearable drug delivery device including integrated pumping and activation elements
|
US20110172637A1
(en)
*
|
2010-01-08 |
2011-07-14 |
Ratio, Inc. |
Drug delivery device including tissue support structure
|
US9014779B2
(en)
|
2010-02-01 |
2015-04-21 |
Proteus Digital Health, Inc. |
Data gathering system
|
US9500186B2
(en)
|
2010-02-01 |
2016-11-22 |
Medipacs, Inc. |
High surface area polymer actuator with gas mitigating components
|
SG182824A1
(en)
|
2010-02-01 |
2012-09-27 |
Proteus Biomedical Inc |
Two-wrist data gathering system
|
DE102010026879A1
(de)
|
2010-02-11 |
2011-08-11 |
AMW GmbH, 83627 |
Transdermales System mit Immunmodulator
|
DE102010026883A1
(de)
|
2010-03-11 |
2011-12-15 |
Amw Gmbh |
Transdermales System mit Aromatasehemmer
|
DK2557924T3
(da)
|
2010-04-13 |
2019-09-23 |
Relmada Therapeutics Inc |
Dermale farmaceutiske sammensætninger af 1-methyl-2',6'-pipecoloxylidid og fremgangsmåde til deres anvendelse
|
DE102011100619A1
(de)
|
2010-05-05 |
2012-01-05 |
Amw Gmbh |
Transdermales therapeutisches System (TTS) mit einem Gehalt an einem Opiod-Analgetikum
|
DE102010024105A1
(de)
*
|
2010-06-17 |
2011-12-22 |
Grünenthal GmbH |
Transdermale Verabreichung von Memantin
|
DE102010026903A1
(de)
|
2010-07-12 |
2012-01-12 |
Amw Gmbh |
Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff
|
JP2013539484A
(ja)
|
2010-08-05 |
2013-10-24 |
バイオフィルム・アイピー・リミテッド・ライアビリティ・カンパニー |
シクロシロキサン置換ポリシロキサン化合物、該化合物を含有する組成物およびそれらの使用法
|
WO2012061556A1
(en)
|
2010-11-03 |
2012-05-10 |
Flugen, Inc. |
Wearable drug delivery device having spring drive and sliding actuation mechanism
|
WO2012092165A1
(en)
|
2010-12-29 |
2012-07-05 |
Noven Pharmaceuticals, Inc. |
Transdermal drug delivery system comprising levonorgestrel acetate
|
US20120219516A1
(en)
|
2011-02-25 |
2012-08-30 |
L'oreal S.A. |
Cosmetic compositions having long lasting shine
|
KR20120107153A
(ko)
*
|
2011-03-15 |
2012-10-02 |
아이큐어 주식회사 |
펜타닐 경피 패치제
|
CN103547258B
(zh)
|
2011-03-17 |
2017-10-20 |
特兰斯德梅尔生物工艺股份有限公司 |
局部一氧化氮系统及其使用方法
|
US11786455B2
(en)
|
2011-05-10 |
2023-10-17 |
Itochu Chemical Frontier Corporation |
Non-aqueous patch
|
MX368747B
(es)
*
|
2011-05-10 |
2019-10-14 |
Itochu Chemical Frontier Corp |
Parche no acuoso de lidocaína y un agente de disolución que comprende un ácido orgánico y un polialcohol que están contenidos en un emplaste para usarse en el tratamiento de dolor muscular a través de la piel.
|
US9925264B2
(en)
|
2011-05-10 |
2018-03-27 |
Itochu Chemical Frontier Corporation |
Non-aqueous patch
|
JPWO2012165254A1
(ja)
*
|
2011-05-31 |
2015-02-23 |
久光製薬株式会社 |
ロピニロール含有貼付剤及びその包装体
|
ITMI20111355A1
(it)
*
|
2011-07-20 |
2013-01-21 |
Epifarma Srl |
Cerotto transdermico contenente diclofenac e tiocolchicoside
|
ES2845524T3
(es)
|
2011-09-27 |
2021-07-27 |
Itochu Chemical Frontier Corp |
Parche no acuoso
|
EP2584016A1
(en)
|
2011-10-21 |
2013-04-24 |
Dow Corning Corporation |
Single phase silicone acrylate formulation
|
MX353713B
(es)
*
|
2011-11-04 |
2018-01-24 |
Agile Therapeutics Inc |
Composiciones de administracion dermica y metodos.
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
HRP20211377T1
(hr)
|
2011-11-23 |
2022-01-07 |
Therapeuticsmd, Inc. |
Prirodne kombinirane hormonske supstitucijske formulacije i terapije
|
JP2013139554A
(ja)
|
2011-11-29 |
2013-07-18 |
Dow Corning Corp |
シリコーンアクリレートハイブリッド組成物及び該組成物の製造方法
|
EP2790684B1
(en)
|
2011-12-16 |
2016-10-12 |
3M Innovative Properties Company |
Foldable adhesive composite dressing
|
WO2013096026A1
(en)
|
2011-12-21 |
2013-06-27 |
3M Innovative Properties Company |
Transdermal adhesive patch assembly with removable microneedle array and method of using same
|
US10426739B2
(en)
|
2011-12-21 |
2019-10-01 |
3M Innovative Properties Company |
Adhesive patch assembly with overlay liner and system and method for making same
|
DE102011090178A1
(de)
|
2011-12-30 |
2013-07-04 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System mit geringer Neigung zur Spontankristallisation
|
CA2906274A1
(en)
|
2012-03-14 |
2013-09-19 |
Medipacs, Inc. |
Smart polymer materials with excess reactive molecules
|
US9084839B2
(en)
|
2012-03-27 |
2015-07-21 |
Berry Plastics Corporation |
Adhesive for use on skin
|
DE102012205493A1
(de)
*
|
2012-04-03 |
2013-10-10 |
Acino Ag |
Einen Dopamin-Agonisten enthaltendes transdermales Applikationssystem
|
EP2845241A4
(en)
|
2012-05-02 |
2016-02-10 |
Henkel US IP LLC |
CURABLE ENCAPSULATION AGENTS AND USE THEREOF
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US8871262B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Compositions and methods for treatment of osteoporosis and other indications
|
US8871255B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Treatment of skin and soft tissue infection with nitric oxide
|
US8871258B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Treatment and prevention of learning and memory disorders
|
US8871256B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Methods and systems for treatment of inflammatory diseases with nitric oxide
|
US8871260B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Methods and compositions for muscular and neuromuscular diseases
|
US8871254B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
|
US8871259B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Techniques and systems for treatment of neuropathic pain and other indications
|
US8871257B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
|
US8871261B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Cancer treatments and compositions for use thereof
|
WO2014059104A1
(en)
|
2012-10-10 |
2014-04-17 |
3M Innovative Properties Company |
Applicator and method for applying a microneedle device to skin
|
EP2906284B8
(en)
|
2012-10-10 |
2021-01-20 |
Kindeva Drug Delivery L.P. |
Force-controlled applicator for applying a microneedle device to skin
|
CA2891467A1
(en)
|
2012-10-15 |
2014-04-24 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for the transdermal delivery of methylphenidate
|
WO2014078545A1
(en)
|
2012-11-16 |
2014-05-22 |
3M Innovative Properties Company |
Force-controlled applicator for applying a microneedle device to skin
|
TW201431570A
(zh)
|
2012-11-22 |
2014-08-16 |
Ucb Pharma Gmbh |
用於經皮投服羅替戈汀(Rotigotine)之多天式貼片
|
US20140172118A1
(en)
*
|
2012-12-19 |
2014-06-19 |
Cook Medical Technologies Llc |
Bioactive Compositions, Bioactive Eluting Devices and Methods of Use Thereof
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
AR094289A1
(es)
|
2012-12-28 |
2015-07-22 |
Noven Pharma |
Sistemas de administracion transdermica de farmacos para levonorgestrel y etinil estradiol
|
CA2896055C
(en)
|
2012-12-28 |
2021-02-16 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for transdermal delivery of amphetamine and clonidine
|
MX366230B
(es)
|
2012-12-28 |
2019-07-03 |
Noven Pharma |
Composiciones multipolimericas para liberación transdermica de farmaco.
|
CA2896336C
(en)
*
|
2012-12-28 |
2021-10-19 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for transdermal delivery of non-steroidal anti-inflammatory agents
|
US9072682B2
(en)
|
2012-12-31 |
2015-07-07 |
Mylan Inc. |
Transdermal dosage form for low-melting point active agent
|
WO2014130846A1
(en)
|
2013-02-22 |
2014-08-28 |
Seungpyo Hong |
Transdermal drug delivery using amphiphilic dendron-coil micelles
|
US9295636B2
(en)
|
2013-03-13 |
2016-03-29 |
Transdermal Biotechnology, Inc. |
Wound healing using topical systems and methods
|
US9724419B2
(en)
|
2013-03-13 |
2017-08-08 |
Transdermal Biotechnology, Inc. |
Peptide systems and methods for metabolic conditions
|
US9314433B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Methods and systems for treating or preventing cancer
|
US9750787B2
(en)
|
2013-03-13 |
2017-09-05 |
Transdermal Biotechnology, Inc. |
Memory or learning improvement using peptide and other compositions
|
US9295637B2
(en)
|
2013-03-13 |
2016-03-29 |
Transdermal Biotechnology, Inc. |
Compositions and methods for affecting mood states
|
US9295647B2
(en)
|
2013-03-13 |
2016-03-29 |
Transdermal Biotechnology, Inc. |
Systems and methods for delivery of peptides
|
US9393264B2
(en)
|
2013-03-13 |
2016-07-19 |
Transdermal Biotechnology, Inc. |
Immune modulation using peptides and other compositions
|
US9339457B2
(en)
|
2013-03-13 |
2016-05-17 |
Transdermal Biotechnology, Inc. |
Cardiovascular disease treatment and prevention
|
US9241899B2
(en)
|
2013-03-13 |
2016-01-26 |
Transdermal Biotechnology, Inc. |
Topical systems and methods for treating sexual dysfunction
|
US20140271938A1
(en)
|
2013-03-13 |
2014-09-18 |
Transdermal Biotechnology, Inc. |
Systems and methods for delivery of peptides
|
US9314417B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Treatment of skin, including aging skin, to improve appearance
|
US9393265B2
(en)
|
2013-03-13 |
2016-07-19 |
Transdermal Biotechnology, Inc. |
Wound healing using topical systems and methods
|
CN105209084B
(zh)
|
2013-03-13 |
2018-07-03 |
艾利丹尼森公司 |
改善的粘合性能
|
US9320758B2
(en)
|
2013-03-13 |
2016-04-26 |
Transdermal Biotechnology, Inc. |
Brain and neural treatments comprising peptides and other compositions
|
US9687520B2
(en)
|
2013-03-13 |
2017-06-27 |
Transdermal Biotechnology, Inc. |
Memory or learning improvement using peptide and other compositions
|
US20140271937A1
(en)
|
2013-03-13 |
2014-09-18 |
Transdermal Biotechnology, Inc. |
Brain and neural treatments comprising peptides and other compositions
|
US9320706B2
(en)
|
2013-03-13 |
2016-04-26 |
Transdermal Biotechnology, Inc. |
Immune modulation using peptides and other compositions
|
US9314422B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Peptide systems and methods for metabolic conditions
|
US20140271731A1
(en)
|
2013-03-13 |
2014-09-18 |
Transdermal Biotechnology, Inc. |
Cardiovascular disease treatment and prevention
|
US9849160B2
(en)
|
2013-03-13 |
2017-12-26 |
Transdermal Biotechnology, Inc. |
Methods and systems for treating or preventing cancer
|
US9387159B2
(en)
|
2013-03-13 |
2016-07-12 |
Transdermal Biotechnology, Inc. |
Treatment of skin, including aging skin, to improve appearance
|
CN105228598A
(zh)
*
|
2013-03-13 |
2016-01-06 |
艾利丹尼森公司 |
从粘合剂提高的药物递送
|
US9314423B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Hair treatment systems and methods using peptides and other compositions
|
US11337936B2
(en)
|
2013-03-14 |
2022-05-24 |
Noven Pharmaceuticals, Inc. |
Amphetamine transdermal compositions with acrylic block copolymer
|
AR095260A1
(es)
|
2013-03-15 |
2015-09-30 |
Noven Pharma |
Composiciones de anfetaminas transdérmicas estables y métodos de fabricación
|
AR095259A1
(es)
|
2013-03-15 |
2015-09-30 |
Noven Pharma |
Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria
|
JP2016517707A
(ja)
|
2013-03-22 |
2016-06-20 |
スリーエム イノベイティブ プロパティズ カンパニー |
カウンタ組立体を備えているマイクロニードルアプリケータ
|
EP2999444A4
(en)
*
|
2013-05-20 |
2016-10-12 |
Mylan Inc |
TRANSDERMAL THERAPEUTIC SYSTEM FOR PROLONGED RELEASE DOSAGE OF PRAMIPEXOLE IN THE TREATMENT OF NEUROLOGICAL DISORDERS
|
EP3003458B1
(en)
|
2013-05-31 |
2019-12-04 |
3M Innovative Properties Company |
Microneedle injection apparatus comprising a dual cover
|
KR101615592B1
(ko)
|
2013-05-31 |
2016-04-26 |
쓰리엠 이노베이티브 프로퍼티즈 컴파니 |
역 작동기를 포함하는 마이크로니들 주사 장치
|
EP3003457B8
(en)
|
2013-05-31 |
2021-02-24 |
Kindeva Drug Delivery L.P. |
Microneedle injection and infusion apparatus
|
JP5415645B1
(ja)
|
2013-06-28 |
2014-02-12 |
久光製薬株式会社 |
貼付剤の製造方法、貼付剤及び包装体
|
ES2694662T3
(es)
|
2013-07-03 |
2018-12-26 |
Lts Lohmann Therapie-Systeme Ag |
Sistema terapéutico transdérmico con componente electrónico
|
ITTO20130663A1
(it)
*
|
2013-08-02 |
2015-02-03 |
Abc Farmaceutici S P A |
Sistema di somministrazione transdermico per l'impiego nel trattamento di patologie croniche bronco-polmonari
|
US9642895B2
(en)
|
2013-08-12 |
2017-05-09 |
3M Innovative Properties Company |
Peptides for enhancing transdermal delivery
|
EP3038608B1
(en)
*
|
2013-08-30 |
2018-01-03 |
3M Innovative Properties Company |
Estradiol containing transdermal drug delivery systems and compositions
|
TWI629066B
(zh)
|
2013-10-07 |
2018-07-11 |
帝國製藥美國股份有限公司 |
使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物
|
KR101948779B1
(ko)
|
2013-10-07 |
2019-05-21 |
테이코쿠 팔마 유에스에이, 인코포레이티드 |
덱스메데토미딘 경피 전달 장치 및 이의 사용 방법
|
US10987342B2
(en)
|
2013-10-07 |
2021-04-27 |
Teikoku Pharma Usa, Inc. |
Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine
|
EP4238580A3
(en)
*
|
2014-05-20 |
2023-10-25 |
LTS Lohmann Therapie-Systeme AG |
Transdermal delivery system including an interface mediator
|
CA2948219C
(en)
|
2014-05-20 |
2023-04-04 |
Lts Lohmann Therapie-Systeme Ag |
Method for adjusting the release of active agent in a transdermal delivery system
|
CA2948220C
(en)
|
2014-05-20 |
2023-06-20 |
Lts Lohmann Therapie-Systeme Ag |
Transdermal delivery system containing rotigotine
|
CA2947767A1
(en)
|
2014-05-22 |
2015-11-26 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
EP3020398A1
(en)
|
2014-11-17 |
2016-05-18 |
Nitto Denko Corporation |
Compounds and formulations for reducing scarring
|
US10028904B2
(en)
|
2014-12-04 |
2018-07-24 |
Wisconsin Alumni Research Foundation |
Transdermal cannabinoid formulations
|
US9375417B2
(en)
|
2014-12-04 |
2016-06-28 |
Mary's Medicinals LLC |
Transdermal cannabinoid formulations
|
US10478346B2
(en)
|
2014-12-18 |
2019-11-19 |
3M Innovative Properties Company |
Methods of handling adhesive laminate patches
|
US10406116B2
(en)
|
2015-02-06 |
2019-09-10 |
Noven Pharmaceuticals, Inc. |
Pressure-sensitive adhesives for transdermal drug delivery
|
KR102565565B1
(ko)
|
2015-02-06 |
2023-08-09 |
노벤 파머수티컬즈, 인코퍼레이티드 |
경피 약물 전달용 감압 접착제
|
EP3267982A4
(en)
*
|
2015-03-13 |
2018-11-07 |
Amneal Pharmaceuticals LLC |
Fentanyl transdermal delivery system
|
US20180169034A1
(en)
|
2015-06-14 |
2018-06-21 |
Trs Ii, Llc |
Transdermal delivery formulation
|
JP7257739B2
(ja)
|
2015-07-02 |
2023-04-14 |
ノーヴェン ファーマシューティカルズ インコーポレイテッド |
レボノルゲストレルおよびエチニルエストラジオールのための経皮的薬物送達システム
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
JP6304457B2
(ja)
*
|
2015-08-27 |
2018-04-04 |
東洋インキScホールディングス株式会社 |
貼付剤
|
CN108601749A
(zh)
|
2016-02-05 |
2018-09-28 |
3M创新有限公司 |
具有氟代硅氧烷剥离衬件的透皮药物递送体系
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
JP2019513709A
(ja)
|
2016-04-01 |
2019-05-30 |
セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. |
ステロイドホルモン薬学的組成物
|
JP7174632B2
(ja)
*
|
2016-06-23 |
2022-11-17 |
コリウム, インコーポレイテッド |
親水性ドメインおよび疎水性ドメインならびに処置剤との接着剤マトリックス
|
US9650338B1
(en)
|
2016-07-29 |
2017-05-16 |
VDM Biochemicals, Inc. |
Opioid antagonist compounds and methods of making and using
|
EP3287462A1
(en)
|
2016-08-25 |
2018-02-28 |
Nitto Denko Corporation |
Isosorbide derivatives to treat bacterial biofilms
|
CA3047354A1
(en)
|
2016-12-20 |
2018-06-28 |
Lts Lohmann Therapie-Systeme Ag |
Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
|
EP3558275A1
(en)
|
2016-12-20 |
2019-10-30 |
LTS Lohmann Therapie-Systeme AG |
Transdermal therapeutic system containing asenapine
|
DE102017104026A1
(de)
|
2017-02-27 |
2018-08-30 |
Lts Lohmann Therapie-Systeme Ag |
Nicotin enthaltendes transparentes transdermales therapeutisches System
|
EP3644973B1
(en)
|
2017-06-26 |
2021-03-24 |
LTS LOHMANN Therapie-Systeme AG |
Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer
|
BR112020007011A2
(pt)
*
|
2017-10-11 |
2020-10-06 |
Lts Lohmann Therapie-Systeme Ag |
sistema terapêutico transdérmico para a administração transdérmica de guanfacina compreendendo pelo menos um aditivo
|
EP3694496A1
(en)
*
|
2017-10-11 |
2020-08-19 |
LTS Lohmann Therapie-Systeme AG |
Transdermal therapeutic system for the transdermal administration of guanfacine comprising a silicone polymer
|
EP3775086B1
(en)
|
2018-04-05 |
2022-09-14 |
3M Innovative Properties Company |
Gel adhesive comprising crosslinked blend of polydiorganosiloxane and acrylic polymer
|
TWI832854B
(zh)
*
|
2018-04-25 |
2024-02-21 |
美商神經治療股份有限公司 |
丁苯那嗪經皮輸送裝置
|
CN112704672A
(zh)
|
2018-06-20 |
2021-04-27 |
罗曼治疗系统股份公司 |
含有阿塞那平的透皮治疗系统
|
CA3113399C
(en)
*
|
2018-09-19 |
2023-09-26 |
Isp Investments Llc |
Peroxide stable polymer composition and process for its preparation and applications thereof
|
US20210346662A1
(en)
|
2018-10-23 |
2021-11-11 |
Kindeva Drug Delivery L.P. |
Tamper evident transdermal patch
|
KR102054346B1
(ko)
*
|
2019-06-20 |
2019-12-10 |
한국지질자원연구원 |
알파 교감신경 차단제 화합물 및 점토광물의 복합체를 포함하는 방출성이 제어된 경구투여용 조성물
|
DE102019120403A1
(de)
*
|
2019-07-29 |
2021-02-04 |
Lts Lohmann Therapie-Systeme Ag |
Verfahren zur Herstellung von Haftklebemassen zur Verwendung in einem transdermalen therapeutischen System
|
WO2021041800A1
(en)
|
2019-08-30 |
2021-03-04 |
Remedy Diagnostics LLC |
Transdermal device comprising pain molecules
|
CN110693857B
(zh)
*
|
2019-10-17 |
2023-08-11 |
宜昌人福药业有限责任公司 |
一种舒芬太尼透皮贴剂及其制备方法
|
RU2736081C1
(ru)
*
|
2019-12-02 |
2020-11-11 |
федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации |
Пластырь трансдермальный с гликлазидом
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|